Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
1.040
+0.105 (11.23%)
At close: May 29, 2026, 4:00 PM EDT
1.050
+0.010 (0.96%)
After-hours: May 29, 2026, 5:33 PM EDT
Oncolytics Biotech Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Oncolytics Biotech stock has a consensus rating of "Buy" and an average price target of $5.37. The average 1-year stock price forecast is 416.35% higher than the current stock price, while the lowest is $2.94 (+182.69%) and the highest is $10.01 (+862.50%).
Price Target: $5.37 (+416.35%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Oncolytics Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 2 | 2 |
| Buy | 3 | 3 | 2 | 2 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +861.54% | May 26, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $3 | Buy | Reiterates | $3 | +188.46% | May 21, 2026 |
| Lake Street | Lake Street | Buy Maintains $5 | Buy | Maintains | $5 | +380.77% | May 5, 2026 |
| JonesTrading | JonesTrading | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Apr 10, 2026 |
Financial Forecast
Revenue This Year
2.02M
Revenue Next Year
52.62M
from 2.02M
Increased by 2,505.00%
EPS This Year
-0.35
from -0.30
EPS Next Year
-0.27
from -0.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 6.3M | 109.4M | |||||
| Avg | 2.0M | 52.6M | |||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | - | 5,316.3% | |||||
| Avg | - | 2,505.0% | |||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.29 | -0.13 |
| Avg | -0.35 | -0.27 |
| Low | -0.38 | -0.41 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.